MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case ...

TORONTO and HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the ...

Step-by-step guide to mastering Meta Ray-Ban Smart Glasses setup and usage for a seamless and hands-free connected experience. Ray-Ban - Official site Meta Ray-Ban Smart Glasses blend style and ...

Motion smoothing has a bad reputation among most cinephiles, as well as many home theater enthusiasts and content creators. Also known as motion or video interpolation, motion smoothing is available ...

(RTTNews) - IO Biotech (IOBT), a clinical-stage biopharmaceutical company focused on cancer vaccines, Monday reported positive phase 3 results for Cylembio, in combination with Merck & Co Inc.'s (MRK) ...

Patients treated with Cylembio (imsapepimut and etimupepimut, adjuvanted) plus pembrolizumab achieved improvement in progression free survival (PFS) compared to patients treated with pembrolizumab ...

PERTH, Australia, Aug. 7, 2025 /PRNewswire/ -- Advanced Spatial technologies (ASt), a premier provider of digital solutions across ANZ and Southeast Asia, is proud to announce its strategic ...

Welcome to Winged Canvas, your Online School of Illustration and Art Nerd Community! 🌟 We're not just a YouTube channel; we're a collective of passionate artists and educators on a mission to make ...

Pertuzumab plus trastuzumab (P+T) in patients (pts) with bladder (BC) and ovarian cancer (OC) with ERBB2/3 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) ...